评价再监禁的 HIV 或 AIDS 患者的免疫和病毒学功能。

Evaluation of Immunologic and Virologic Function in Reincarcerated Patients Living With HIV or AIDS.

机构信息

Department of Pharmacy Practice, Section of Infectious Diseases Pharmacotherapy, University of Illinois at Chicago, College of Pharmacy, Chicago, Illinois, USA.

Department of Medicine, Division of Infectious Diseases, University of Illinois at Chicago, College of Medicine, Chicago, Illinois, USA.

出版信息

J Correct Health Care. 2022 Jun;28(3):203-206. doi: 10.1089/jchc.20.07.0055. Epub 2022 Apr 21.

Abstract

Despite receipt of antiretroviral therapy (ART) while incarcerated, formerly incarcerated individuals living with HIV may experience numerous barriers to follow-up HIV care and continuation of ART once released from prison. The goal of this retrospective electronic medical chart review was to determine virologic and immunologic function of individuals living with HIV who were reincarcerated within the Illinois Department of Corrections. Of 200 patients reincarcerated during the study period, 167 met inclusion criteria. The rate of participants who were on ART and virologically suppressed decreased from 73% at time of release to 49.7% at time of reincarceration ( < .01). Of the 57 individuals who did not engage in follow-up, 39% were virologically suppressed at time of reincarceration. Despite virologic suppression while incarcerated, increased linkage, engagement, and retention in medical care upon release from prison is essential in maintaining virologic suppression.

摘要

尽管在监禁期间接受了抗逆转录病毒疗法(ART),但患有 HIV 的前囚犯在出狱后可能会面临许多后续 HIV 护理和继续接受 ART 的障碍。本回顾性电子病历审查的目的是确定在伊利诺伊州惩教署再次被监禁的 HIV 感染者的病毒学和免疫学功能。在研究期间被重新监禁的 200 名患者中,有 167 名符合纳入标准。在释放时接受 ART 治疗且病毒学抑制的参与者比例从 73%下降到再次入狱时的 49.7%( < .01)。在未进行随访的 57 人中,有 39%在再次入狱时病毒学抑制。尽管在监禁期间病毒学得到抑制,但在出狱后增加与医疗保健的联系、参与和保留对于维持病毒学抑制至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索